MedPath

Sample Collection Study for Scientific Evaluation of Laboratory Interference of CyFlow Antibodies for Flow Cytometry

Recruiting
Conditions
Sample Collection Study for Scientific Evaluation of Laboratory Interference of CyFlow™ Antibodies for Flow Cytometry
Registration Number
DRKS00033260
Lead Sponsor
PSHI Praxis GmbH
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Recruiting
Sex
All
Target Recruitment
65
Inclusion Criteria

• Patients who are subject to a medically indicated venous blood draw in the course of daily routine practice.
• Subjects who agree to the drawing of an additional 9 mL blood sample through the venous line in place that will be used for laboratory tests.

Exclusion Criteria

• Lack of compliance or other justifications that precludes satisfactory participation in the study in the opinion of the Investigator.
• Inability to understand the nature and the extent of the study and the procedures required.
• Participation without legal capacity
• Pregnant and nursing women

Study & Design

Study Type
observational
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Collection of venous blood samples for in-vitro Interference tests for CyFlow™ antibody products. Venous blood draw of 9 ml EDTA whole blood during visit 1.<br><br>The study has no regular primary endpoint. <br>The aim of the study is the determination of interference of the CyFlow™ antibody products in the laboratory.
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath